...
首页> 外文期刊>Bone marrow transplantation >Treatment of pure red cell aplasia after major ABO-incompatible peripheral blood stem cell transplantation by induction of chronic graft-versus-host disease.
【24h】

Treatment of pure red cell aplasia after major ABO-incompatible peripheral blood stem cell transplantation by induction of chronic graft-versus-host disease.

机译:通过诱导慢性移植物抗宿主病治疗主要ABO不相容的外周血干细胞移植后的纯红细胞发育不良。

获取原文
获取原文并翻译 | 示例
           

摘要

This report concerns a case of long-lasting pure red cell aplasia (PRCA) with a duration of 178 days after major ABO-incompatible allogeneic peripheral blood stem cell transplantation (PBSCT). The patient needed red blood cell transfusion every week from day 54 following PBSCT. He showed no evidence of GVHD and the dose of cyclosporin A (CsA) was reduced rapidly from day 123, followed by the development of chronic GVHD around day 145. The patient no longer needed transfusions from day 167, the reticulocyte count began to increase on day 179, and antidonor isohemagglutinin titers became undetectable. Chronic GVHD induced by tapering of CsA thus appeared to be related to improvement in PRCA.
机译:该报告涉及一例持久的纯红细胞发育不全(PRCA),在严重的ABO不相容异体外周血干细胞移植(PBSCT)后持续178天。从PBSCT后的第54天起,患者每周需要输血一次。他没有显示出GVHD的证据,并且从第123天起环孢菌素A(CsA)的剂量迅速减少,随后在第145天左右发展为慢性GVHD。患者从第167天起不再需要输血,网织红细胞计数开始增加在第179天,抗供体异血凝素滴度变得不可检测。因此,由逐渐变细的CsA诱导的慢性GVHD与PRCA的改善有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号